4//SEC Filing
Baldry Mark 4
Accession 0000899243-19-021293
CIK 0001631574other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 7:16 PM ET
Size
9.1 KB
Accession
0000899243-19-021293
Insider Transaction Report
Form 4
Baldry Mark
Chief Commerical Officer
Transactions
- Award
Ordinary Shares
2019-08-05+35,000→ 35,000 total - Award
Ordinary Shares
2019-08-05+4,000→ 39,000 total - Award
Share Option (right to buy)
2019-08-05+25,000→ 25,000 totalExercise: $19.48Exp: 2029-08-05→ Ordinary Shares (25,000 underlying)
Footnotes (3)
- [F1]Consists of restricted share units (RSUs). The RSUs vest in four equal annual installments of 25% on August 5, 2020 through August 5, 2023.
- [F2]Consists of RSUs. The RSUs vest as to 50% on August 5, 2020 and 50% on August 5, 2021.
- [F3]The option vests as to 25% of the shares on August 5, 2020 and the remainder vests quarterly thereafter until August 5, 2023.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001644137
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 7:16 PM ET
- Size
- 9.1 KB